Effects of vaccination and population structure on influenza epidemic spread in the presence of two circulating strains

Alexander, Murray E.; Kobes, Randy
January 2011
BMC Public Health;2011 Supplement 1, Vol. 11 Issue Suppl 1, p1
Academic Journal
Background: Human influenza is characterized by seasonal epidemics, caused by rapid viral adaptation to population immunity. Vaccination against influenza must be updated annually, following surveillance of newly appearing viral strains. During an influenza season, several strains may be co-circulating, which will influence their individual evolution; furthermore, selective forces acting on the strains will be mediated by the transmission dynamics in the population. Clearly, viral evolution and public health policy are strongly interconnected. Understanding population-level dynamics of coexisting viral influenza infections, would be of great benefit in designing vaccination strategies. Methods: We use a Markov network to extend a previous homogeneous model of two co-circulating influenza viral strains by including vaccination (either prior to or during an outbreak), age structure, and heterogeneity of the contact network. We explore the effects of changes in vaccination rate, cross-immunity, and delay in appearance of the second strain, on the size and timing of infection peaks, attack rates, and disease-induced mortality rate; and compare the outcomes of the network and corresponding homogeneous models. Results: Pre-vaccination is more effective than vaccination during an outbreak, resulting in lower attack rates for the first strain but higher attack rates for the second strain, until a "threshold" vaccination level of ~30-40% is reached, after which attack rates due to both strains sharply dropped. A small increase in mortality was found for increasing pre-vaccination coverage below about 40%, due to increasing numbers of strain 2 infections. The amount of cross-immunity present determines whether a second wave of infection will occur. Some significant differences were found between the homogeneous and network models, including timing and height of peak infection(s). Conclusions: Contact and age structure significantly influence the propagation of disease in the population. The present model explores only qualitative behaviour, based on parameters derived for homogeneous influenza models, but may be used for realistic populations through statistical estimates of inter-age contact patterns. This could have significant implications for vaccination strategies in realistic models of populations in which more than one strain is circulating.


Related Articles

  • Tiered Use of Inactivated Influenza Vaccine in the Event of a Vaccine Shortage.  // JAMA: Journal of the American Medical Association;9/14/2005, Vol. 294 Issue 10, p1204 

    Discusses the tiered use of inactivated influenza vaccine when there is a vaccine shortage in the United States. The estimated number of doses of inactivated vaccine and attenuated vaccine needed for the 2005-2006 influenza season, which is calculated by the Advisory Committee on Immunization...

  • Influenza Pandemic: Plan Needed for Federal and State Response: GAO-01-4.  // GAO Reports;10/27/2000, p1 

    Public health experts have raised concerns about the ability of the nation's public health system to detect and respond to emerging infectious disease threats, such as pandemic influenza. Although vaccines are considered the first line of defense to prevent or reduce influenza-related illness...

  • Ocular Vaccinia: A Consequence of Unrecognized Contact Transmission. Montgomery, Jay R.; Carroll, Robert B.; McCollum, Andrea M. // Military Medicine;Jun2011, Vol. 176 Issue 6, p699 

    A patient developed severe ocular vaccinia via autoinoculation after acquiring unrecognized contact-transmitted vaccinia from wrestling with vaccinated members of his unit. This case highlights both the need to reinforce infection-control measures among vaccinees and the need for providers to be...

  • Clinical digest. VACCINATING CHILDREN IS COST-EFFECTIVE FOR TACKLING FLU BURDEN.  // Nursing Standard;10/28/2015, Vol. 30 Issue 9, p14 

    The article discusses a study which found that extending the national flu vaccination program to children aged 5 to 16 years is a cost-effective way to reduce disease burden in the general population.

  • HHS Piles on Swine Flu Money: $884M More for H1N1 Vaccine. Young, Donna // BioWorld Today;7/14/2009, Vol. 20 Issue 133, p3 

    The article reports that the U.S. government will allocate $884 million to buy more H1N1 vaccine. According to Health and Human Services Secretary Kathleen Sebelius, the National Institute of Health (NIH) and Food and Drug Administration (FDA) are collaborating to develop better swine flu...

  • INFLUENZA VACCINATION FOR HEALTH CARE WORKERS: TOWARDS A WORKABLE AND EFFECTIVE STANDARD. Rodal, Rebecca; Ries, Nola M.; Wilson, Kumanan // Health Law Journal;2009, Vol. 17, p297 

    The article discusses the importance of mandatory health care policies related to influenza vaccination for health care workers in Canada. The policy was rejected due to the notion that the vaccination is ineffective and unneeded, expressing fear for its inauspicious effects. The article also...

  • Recommended Adult Immunization Schedule—United States, October 2005–September 2006.  // JAMA: Journal of the American Medical Association;11/23/2005, Vol. 294 Issue 20, p2569 

    The article reports on the "Recommended Adult Immunization Schedule--United States, October 2005-September 2006." The Advisory Committee on Immunization Practices reviews and approves the schedule for licensed vaccines such as MMR, influenza, tetanus and diphtheria, varicella, pneumococcal...

  • Muddle over pay for flu vaccination.  // Pulse;11/17/2003, Vol. 63 Issue 46, p8 

    Reports that the British government has issued conflicting advice over payments for giving the influenza vaccine.

  • NI extends flu jab to all children.  // Community Practitioner;Oct2012, Vol. 85 Issue 10, p8 

    The article reports that flu vaccine will be given to all children aged between 2-17, free of charge in Ireland, following a recommendation from the Joint Committee on Vaccination and Immunisation (JCVI).


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics